Clinical Trials Browser

Phase 2 × Recruiting × Vaccines, DNA × Clear all

NCT05799144 2025-10-22

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Phase 2 Recruiting

Oropharyngeal Neoplasms